Pharmaceutical brands: Abilify (BMS/Otsuka)

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista Dossier about Bristol-Myers Squibb's top brand Abilify

This dossier presents graphs and tables about Bristol-Myers Squibb and its top brand Abilify manufactured by this pharmaceutical company (together with Otsuka). It provides key product facts, product sales, rankings, price developments, and advertising expenditures.

Table of contents

  • 1. Overview
    • Top pharmaceutical products by sales worldwide 2017

    • U.S. top 20 prescribed drugs based on sales 2016

    • Revenue of top 20 neurology products in the U.S. 2016

    • Revenue of Abilify globally by region 2011-2016

    • Top U.S. pharmaceutical patent expiries by revenue 2014-2016

  • 2. Drug prices and consumer behavior
    • U.S. household expenditure on prescription drugs 2007-2016

    • Price disparities for top product Abilify - U.S. and international 2017

  • 3. Advertising expenditures
    • Bristol-Myers Squibb's ad and promo spending 2011-2017

    • Ad spend of selected prescription drug brands in the U.S. 2017

    • Journal spend of neurology products in the U.S. 2015

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

News
News